Alessa Therapeutics, Inc.
PrivateLast Round
VC Round
May 1, 2025
Total Funding Raised
$18.35M
Company Overview
Alessa Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in San Carlos, California. Its latest recorded funding round was a VC Round in May 2025.
Alessa Therapeutics, Inc. is a biotechnology company that develops proprietary localized drug delivery technology for the early interception and treatment of prostate cancer and other solid organ diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alessa Therapeutics, Inc. Comparables
Compare Alessa Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanTher Therapeutics | 85% | |
| Postsurgical Therapeutics, Inc. | 80% | |
| NanOlogy, LLC | 79% |
For institutional investors. Book with your work email.
Alessa Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 1, 2025 | ||||
| Seed | Dec 12, 2024 | ||||
| Grant | Aug 4, 2021 | ||||
| Seed | Mar 21, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Alessa Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioInnovation Capital | Seed |
| Mission BioCapital | VC Round, Seed |
| Cure Ventures | VC Round |
| Johnson & Johnson Innovation – JJDC | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
| Mission Bay Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Will present at the 44th Annual J.P. Morgan Healthcare Conference.
- May 1, 2025
$25.4M raised with participation from Cure Ventures and Mission BioCapital.
For institutional investors. Book with your work email.
Alessa Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alessa Therapeutics, Inc.'s valuation, stock price, and market status.
Is Alessa Therapeutics, Inc. a public or private company?
Alessa Therapeutics, Inc. is a private company.
What is the current stock price of Alessa Therapeutics, Inc.?
Alessa Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Alessa Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alessa Therapeutics, Inc. worth (valuation)?
Valuation information for Alessa Therapeutics, Inc. is not publicly available.
Can I buy Alessa Therapeutics, Inc. stock?
Alessa Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alessa Therapeutics, Inc.'s last funding round?
Alessa Therapeutics, Inc.'s most recent funding round was VC Round on May 1, 2025.
Who are the main investors in Alessa Therapeutics, Inc.?
Key investors in Alessa Therapeutics, Inc. include Mission BioCapital.
Will Alessa Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Alessa Therapeutics, Inc..
How can I track Alessa Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Alessa Therapeutics, Inc.'s shares on secondary markets.